Terms: = Prostate cancer AND MED12, Q93074, TRAP230, TNRC11, OKS, KIAA0192, HOPA, FGS1, CAGH45, ARC240, 9968
20 results:
1. Molecular complexity of intraductal carcinoma of the prostate.
Zhu S; Xu N; Zeng H
Cancer Med; 2024 Jan; 13(2):e6939. PubMed ID: 38379333
[TBL] [Abstract] [Full Text] [Related]
2. Genomic alterations related to HPV infection status in a cohort of Chinese prostate cancer patients.
Lang B; Cao C; Zhao X; Wang Y; Cao Y; Zhou X; Zhao T; Wang Y; Liu T; Liang W; Hu Z; Tian X; Zhang J; Yan Y
Eur J Med Res; 2023 Jul; 28(1):239. PubMed ID: 37461056
[TBL] [Abstract] [Full Text] [Related]
3. Detection of disease-causing mutations in prostate cancer by NGS sequencing.
Mangolini A; Rocca C; Bassi C; Ippolito C; Negrini M; Dell'Atti L; Lanza G; Gafà R; Bianchi N; Pinton P; Aguiari G
Cell Biol Int; 2022 Jul; 46(7):1047-1061. PubMed ID: 35347810
[TBL] [Abstract] [Full Text] [Related]
4. Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized prostate cancer Via Targeted, Multiregion Sequencing.
Chen E; Cario CL; Leong L; Lopez K; Márquez CP; Li PS; Oropeza E; Tenggara I; Cowan J; Simko JP; Kageyama R; Wells DK; Chan JM; Friedlander T; Aggarwal R; Paris PL; Feng F; Carroll PR; Witte JS
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250416
[TBL] [Abstract] [Full Text] [Related]
5. Distinct Genomic Alterations in prostate Tumors Derived from African American Men.
Liu W; Zheng SL; Na R; Wei L; Sun J; Gallagher J; Wei J; Resurreccion WK; Ernst S; Sfanos KS; Isaacs WB; Xu J
Mol Cancer Res; 2020 Dec; 18(12):1815-1824. PubMed ID: 33115829
[TBL] [Abstract] [Full Text] [Related]
6. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
7. The Genomics of prostate cancer: emerging understanding with technologic advances.
Rubin MA; Demichelis F
Mod Pathol; 2018 Jan; 31(S1):S1-11. PubMed ID: 29297493
[TBL] [Abstract] [Full Text] [Related]
8. The mediator complex in genomic and non-genomic signaling in cancer.
Weber H; Garabedian MJ
Steroids; 2018 May; 133():8-14. PubMed ID: 29157917
[TBL] [Abstract] [Full Text] [Related]
9. Presurgical weight loss affects tumour traits and circulating biomarkers in men with prostate cancer.
Demark-Wahnefried W; Rais-Bahrami S; Desmond RA; Gordetsky JB; Hunter GR; Yang ES; Azrad M; Frugé AD; Tsuruta Y; Norian LA; Segal R; Grizzle WE
Br J Cancer; 2017 Oct; 117(9):1303-1313. PubMed ID: 28881355
[TBL] [Abstract] [Full Text] [Related]
10. Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories.
Taylor RA; Fraser M; Livingstone J; Espiritu SM; Thorne H; Huang V; Lo W; Shiah YJ; Yamaguchi TN; Sliwinski A; Horsburgh S; Meng A; Heisler LE; Yu N; Yousif F; Papargiris M; Lawrence MG; Timms L; Murphy DG; Frydenberg M; Hopkins JF; Bolton D; Clouston D; McPherson JD; van der Kwast T; Boutros PC; Risbridger GP; Bristow RG
Nat Commun; 2017 Jan; 8():13671. PubMed ID: 28067867
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive analysis of the transcriptional profile of the Mediator complex across human cancer types.
Syring I; Klümper N; Offermann A; Braun M; Deng M; Boehm D; Queisser A; von Mässenhausen A; Brägelmann J; Vogel W; Schmidt D; Majores M; Schindler A; Kristiansen G; Müller SC; Ellinger J; Adler D; Perner S
Oncotarget; 2016 Apr; 7(17):23043-23055. PubMed ID: 27050271
[TBL] [Abstract] [Full Text] [Related]
12. Mutation of
Yoon N; Lim S; Kang SY; Kwon GY; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY
Asian J Androl; 2017; 19(3):346-349. PubMed ID: 26924278
[TBL] [Abstract] [Full Text] [Related]
13. Suppression of BCL2 by Antisense Oligonucleotides and Compensation by Non-Targeted Genes May Enhance Tumor Proliferation.
Rubenstein M; Hollowell CM; Guinan P
In Vivo; 2015; 29(6):687-93. PubMed ID: 26546525
[TBL] [Abstract] [Full Text] [Related]
14. Somatic med12 mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms.
Kämpjärvi K; Kim NH; Keskitalo S; Clark AD; von Nandelstadh P; Turunen M; Heikkinen T; Park MJ; Mäkinen N; Kivinummi K; Lintula S; Hotakainen K; Nevanlinna H; Hokland P; Böhling T; Bützow R; Böhm J; Mecklin JP; Järvinen H; Kontro M; Visakorpi T; Taipale J; Varjosalo M; Boyer TG; Vahteristo P
Prostate; 2016 Jan; 76(1):22-31. PubMed ID: 26383637
[TBL] [Abstract] [Full Text] [Related]
15. med12 overexpression is a frequent event in castration-resistant prostate cancer.
Adler D; Offermann A; Braun M; Menon R; Syring I; Nowak M; Halbach R; Vogel W; Ruiz C; Zellweger T; Rentsch CA; Svensson M; Andren O; Bubendorf L; Biskup S; Duensing S; Kirfel J; Perner S
Endocr Relat Cancer; 2014 Aug; 21(4):663-675. PubMed ID: 24938407
[TBL] [Abstract] [Full Text] [Related]
16. med12 mutations in human diseases.
Wang H; Shen Q; Ye LH; Ye J
Protein Cell; 2013 Sep; 4(9):643-6. PubMed ID: 23836153
[TBL] [Abstract] [Full Text] [Related]
17. Lack of evidence for frequent med12 p.L1224F mutation in prostate tumours from Caucasian patients.
Stoehr R; Taubert H; Gaisa NT; Smeets D; Kneitz B; Giedl J; Ruemmele P; Wieland WF; Rau TT; Hartmann A
J Pathol; 2013 Aug; 230(4):453-6. PubMed ID: 23661306
[TBL] [Abstract] [Full Text] [Related]
18. Simultaneous and combined detection of multiple tumor biomarkers for prostate cancer in human serum by suspension array technology.
Liu N; Liang W; Ma X; Li X; Ning B; Cheng C; Ou G; Wang B; Zhang J; Gao Z
Biosens Bioelectron; 2013 Sep; 47():92-8. PubMed ID: 23567627
[TBL] [Abstract] [Full Text] [Related]
19. Exome sequencing identifies recurrent SPOP, FOXA1 and med12 mutations in prostate cancer.
Barbieri CE; Baca SC; Lawrence MS; Demichelis F; Blattner M; Theurillat JP; White TA; Stojanov P; Van Allen E; Stransky N; Nickerson E; Chae SS; Boysen G; Auclair D; Onofrio RC; Park K; Kitabayashi N; MacDonald TY; Sheikh K; Vuong T; Guiducci C; Cibulskis K; Sivachenko A; Carter SL; Saksena G; Voet D; Hussain WM; Ramos AH; Winckler W; Redman MC; Ardlie K; Tewari AK; Mosquera JM; Rupp N; Wild PJ; Moch H; Morrissey C; Nelson PS; Kantoff PW; Gabriel SB; Golub TR; Meyerson M; Lander ES; Getz G; Rubin MA; Garraway LA
Nat Genet; 2012 May; 44(6):685-9. PubMed ID: 22610119
[TBL] [Abstract] [Full Text] [Related]
20. Clinical significance of a solitary hot spot in the skull.
Hashmi R; Uetani M; Ogawa Y; Aziz A
Nucl Med Commun; 1999 Aug; 20(8):703-10. PubMed ID: 10451878
[TBL] [Abstract] [Full Text] [Related]